Newly Identified Pathway, Biomarkers May Be Tools to Prevent Kidney Injury-induced Lung Damage
Article title: Altered lung metabolism and mitochondrial DAMPs in lung injury due to acute kidney injury Authors: Mark Hepokoski, Jing Wang,
Read moreKidney Injury
Drug-Induced Kidney Injury Biomarkers, Epithelial Permeability, and More Featured in March 2021 Toxicological Sciences
The March 2021 issue of Toxicological Sciences includes exciting toxicology research in biotransformation, toxicokinetics, and pharmacokinetics; genetic and epigenetic toxicology; neurotoxicology; and more.
Read moreEnzyme Activation after Acute Kidney Injury May Lead to Tubule Atrophy
Article title: Intratubular epithelial-mesenchymal transition and tubular atrophy after kidney injury in mice Authors: Noriyuki Yamashita, Tetsuro Kusaba, Tomohiro Nakata, Aya Tomita,
Read moreUncovering a ‘suPAR’ culprit behind kidney injury in COVID-19
A new observational study finds patients in the hospital for COVID-19 have high levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.
Read moreComputer-based Modeling Identifies how Cell Death Is Regulated in Ischemic Kidney Injury
Article title: T95 nucleophosmin phosphorylation as a novel mediator and marker of regulated cell death in acute kidney injury Authors:
Read moreResearchers Reveal Target in Acute Kidney Injury Prevention
Physician-Scientists and other researchers at Rush University Medical Center, in collaboration with colleagues at other institutions, have revealed a new treatment target that may help change the outcome for patients at risk of AKI.
Read more
New protein target could lead to breakthrough in kidney injury prevention
Study suggests a protein called suPAR could be targeted to prevent dreaded kidney complications in patients undergoing common medical procedures.
Read moreProtein levels in urine after acute kidney injury predict future loss of kidney function
High levels of protein in a patient’s urine shortly after an episode of acute kidney injury is associated with increased risk of kidney disease progression, providing a valuable tool in predicting those at highest risk for future loss of kidney function.
Read moreStudy Examines Kidney Injury in Patients Taking Immunotherapy Cancer Medications
In patients taking immune checkpoint inhibitors as a treatment for cancer, 17% experienced acute kidney injury (AKI), 8% experienced sustained AKI, and 3% had potential immune checkpoint inhibitor–related AKI.
• Use of proton pump inhibitors, which are commonly used to treat stomach ulcers or acid reflux, was associated with a higher risk of experiencing sustained AKI.